Trial designed to investigate the cardioprotective properties of CardiolRx™ in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease Oakville,...
TSX:CRDL
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx™
Results expected to support the Company’s plans to file an IND application withthe FDA for a Phase II international trial in acute myocarditis Oakville, ON – April 12, 2021 – Cardiol Therapeutics...
Pharma’s $7.2 Billion CBD Acquisition Could Trigger New Biotech Boom
CARDIOL THERAPEUTICS INC. (TSX:CRDL | OTCQX:CRTPF | FRA:CT9) Giant $7.2 Billion Acquisition Validates CBD With Jazz Pharmaceuticals announcing they plan to acquire GW Pharmaceuticals for USD$7.2...
How Cardiol Therapeutics Could Help Save the Most Vulnerable from Dying of COVID-19
CARDIOL THERAPEUTICS INC. (TSX:CRDL | OTCQX:CRTPF | FRA:CT9) A New COVID-19 Breakthrough? As COVID-19 has spread across the globe, taking over 2 million lives over the last year,...